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Objective. To determine if DNA methylation in- 
hibitors make T cells autoreactive by inducing lympho- 
cyte function-associated antigen type 1 (LFA-1) ( C D l l d  
CD18) overexpression. 
Methods. T cell clones were treated with 3 dis- 
tinct DNA methylation inhibitors or were stably trans- 
fected with a CD18 cDNA in a mammalian expression 
vector, and the effects on LFA-1 expression and activa- 
tion requirements were examined. 
Results. LFA-1 overexpression, caused by DNA 
methylation inhibitors or by transfection, correlates 
with the development of autoreactivity. 
Conclusion. LFA-1 overexpression may contrib- 
ute to T cell autoreactivity. 
Investigators at this laboratory have reported 
that human and murine cloned, antigen-specific, 
CD4+ T cells become autoreactive following treatment 
with DNA methylation inhibitors like 5-azacytidine 
(5-azaC) and procainamide (PCA) (1-3). The autoreac- 
tivity has pathologic significance, because T cells made 
autoreactive with these drugs are sufficient to cause a 
lupus-like disease when injected into syngeneic mice (3). 
This system is relevant to human lupus, because PCA 
induces a lupus-like disease in patients receiving this 
drug (4), and because patients with idiopathic lupus have 
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impaired T cell DNA methylation (3, similar to cells 
treated with 5-azaC or PCA. How DNA methylation 
inhibitors modify T cells to induce autoreactivity is, 
however, unknown. 
DNA methylation is one of the mechanisms 
regulating gene expression. In genes regulated by such 
mechanisms, hypomethylation of regulatory se- 
quences correlates with active transcription, while 
methylation of the regulatory sequences correlates 
with transcriptional suppression (6). We have previ- 
ously shown that concentrations of 5-azaC which 
induce autoreactivity also modify T cell gene expres- 
sion (7,8), and proposed that alterations in the expres- 
sion of one or more T cell genes may be responsible for 
the autoreactivity. An extensive search demonstrated 
that the most reproducible change induced by 5-azaC 
was an increase in cell surface leukocyte function- 
associated antigen 1 (LFA-1) (CD1 ldCD18) (8). Fur- 
thermore, small amounts of antLCD1 l a  completely 
inhibited the associated autoreactive response, while 
significantly greater amounts were required to inhibit 
the antigen response of the same cells (8). This sug- 
gested that increased LFA- 1 expression might contrib- 
ute to autoreactivity, and anti-LFA-1 reverse it. How- 
ever, it is also possible that other, as-yet-undetected 
gene products are responsible for the autoreactivity , 
or that the increase in LFA-1 expression does not 
directly cause the autoreactivity . 
In this report we have further examined the role 
of LFA-1 overexpression in T cell autoreactivity. 
First, the correlation between increased LFA-1 ex- 
pression and autoreactivity was confirmed using addi- 
tional, mechanistically distinct DNA methylation in- 
hibitors. Second, LFA-1 expression was increased by 
transfection of T cell clones, and effects on T cell 
activation requirements were examined. The results 
support the hypothesis that LFA- 1 overexpression 
contributes to T cell autoreactivity. 
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MATERIALS AND METHODS 
T cell lines. The human T cell line Jurkat (E6-1) was 
kindly donated by Dr. Arthur Weiss (University of Califor- 
nia at San Francisco) and cultured as previously described 
(2). The cloned, tetanus toxoid (TTbreactive CD4+ human 
T cell lines, including TT18X, TT181, TT37L, TT44G, and 
TT48C, and the cloned CD4+ conalbumin-reactive murine 
line D. 10.G4.1, have been previously described, and all 
demonstrate similar autoreactivity when treated with DNA 
methylation inhibitors (1-33). 
All human lines were cloned from the same donor 
(BR) by limiting dilution using 10 .2  cells/well. Cells were 
maintained in interleukin-2 (IL-2) (supernatant from the 
MLA-144 T cell line [9])-containing media (RPMI 1640 
supplemented with 10% fetal calf serum, penicillin, strepto- 
mycin, and L-glutamine) by periodic rechallenge with TT 
(1 5 0  dilution; Wyeth, Marietta, PA) and irradiated (3,000R) 
autologous peripheral blood mononuclear cells (PBMC) as 
antigen-presenting cells (APC) as described elsewhere (1,2). 
Where indicated, the cells were treated with 5-azaC (Ald- 
rich, Milwaukee, WI) or PCA (Sigma, St. Louis, MO). Phyto- 
hemagglutinin (PHAMctivated, IL-2lependent CD4+ T cells 
were also generated as previously described (10). 
Monoclonal antibodies and flow cytometric analysis. 
Anti-CDlla (TS 1/22, an inhibitor of T cell responses) (11) 
and anti-CD18 (TS 1/18) (1 1) were obtained from the Amer- 
ican Type Culture Collection (Rockville, MD) and main- 
tained according to instructions. The anti-CD1 l a  monoclo- 
nal TA-1, which does not inhibit T cell responses (12), was 
kindly donated by Dr. Tucker LeBien. Anti-CD2-RD1 and 
anti-CD3-RD1 were obtained from Coulter (Hialeah, FL), and 
fluorescein isothiocyanate-conjugated goat anti-mouse Ig was 
obtained from Sigma. 
Direct and indirect immunofluorescence staining 
were performed as previously described (1,7,8), and fluores- 
cence was analyzed using a Coulter EPICS or ELITE flow 
cytometer in 1- or 2-color mode. When data from the EPICS 
were used (reported as log fluorescence intensity), relative 
fluorescence intensity (RFI) between markers was calcu- 
lated using the formula: log RFI = [(A - B)/25.2]logz, where 
A and B represent the mean channel fluorescence or peak 
fluorescence of 2 markers. When the ELITE data were used 
(reported as linear fluorescence intensity), RFI could be 
simply calculated as the difference in intensity. Cell cycle 
analysis was performed using propidium iodide as previously 
described (3,8). 
Ultraviolet (UV) light exposure. Human T cells were 
suspended in 2 mm of phosphate buffered saline (PBS) in 
uncovered 6-cm petri dishes and exposed to light from a 
bank of 6 Westinghouse FS-40 lamps for varying lengths of 
time. The flux of light (J/m2) was measured by an externally 
calibrated LM H 0 6  radiometer (International Light, New- 
buryport, MA). Where indicated, wavelengths <335 nm 
were absorbed using a filter (Schott Glass Technologies, 
Duryea, PA). When the filter was used, exposure times were 
lengthened by a factor of 2.57 to assure that the same amount 
of light energy (J/m2, as measured by the radiometer) was 
applied to the cells. 
Proliferation assays. Proliferation assays were per- 
formed as previously described (2,3). Briefly, IL-2- 
dependent T cells were washed, then cultured in 200 pl of 
medium lacking IL-2, together with irradiated PBMC as 
APC. TT was added where indicated. Controls always 
included T cells and PBMC cultured alone. Proliferation was 
measured 3 days later by tritiated thymidine (New England 
Nuclear, Boston, MA) incorporation (1-3). 
DNA deoxymethylcytosine content. DNA was isolated 
and digested with DNase I, phosphodiesterase, and alkaline 
phosphatase (Sigma) as previously described (23). The 
resulting nucleosides were supplemented with fluorodeoxy- 
uracil (FdU; Sigma) as an internal standard, then separated 
by chromatography on a Beckman (San Ramon, CA) Ultra- 
sphere C18 column (4.6 mm X 25 cm), using a mobile phase 
consisting of 2-3% methanol in 0.01M sodium acetate, pH 
3.5 as described (5).  Eluted material was detected using a 
Waters 990 diode array detector, recording UV spectra from 
220-320 nm every 100 milliseconds. Integrations were per- 
formed at 300 nm, and quantitated relative to standard 
curves generated from purified commercial deoxycytosine 
(dC) and deoxymethylcytosine (d"C), both obtained from 
Sigma. Results are expressed as % d"C = [d"C/(d"C + dC)] 
x 100, and all determinations were performed in duplicate. 
Electroporation. Initial experiments demonstrated 
that 220V and 960 pF gave optimal chloramphenicol acetyl- 
transferase (CAT) expression by a CAT-pSV2 construct in 
IL-2lependent lines. However, CAT expression was low, 
suggesting relatively low transfection efficiency. Therefore, 
long-term, stable transfectants were used, rather than tran- 
sient transfection systems. To generate the stable transfec- 
tants, a full-length human CDl l a  complementary DNA 
(cDNA) cloned into CDM8 (13), kindly donated by Dr. Tim 
Springer, and a full-length human CD18 cDNA cloned into 
pEMO, kindly donated by Dr. James Wilson (14), were used. 
Control vectors included CDM8 and pEMO without inserts. 
For transfection, the CDM8 constructs were linear- 
ized with Nhe I and the pEMO constructs with Nde I (both 
from Boehringer Mannheim, Indianapolis, IN). T cell clones 
were washed with PBS, and 19 x lo6 were suspended in 1 ml 
of sterile HEPES electroporation buffer (20 mM HEPES, 137 
mM NaCI, 5 mM KCl, 0.7 mM Na2HP0,, 6 mM dextrose, pH 
7.05) in an electroporation cuvette. Linearized construct (1 1-15 
pg) was added, the mixture incubated at 4°C for 10 minutes, 
then electroporated at 220V and 960 pF, using a Gene Pulsar 
with capacitance extender (Bio-Rad, Hercules, CA). The cells 
were again incubated at 4°C for 10 minutes, washed once, then 
cultured at 106/ml in IL-2-containing media, using 24-well 
plates (Falcon; Becton Dickinson, Lincoln Park, NJ). The next 
day, lo6 irradiated autologous PBMC were added to each well, 
and the cells were maintained as long-term lines with IL-2 and 
periodic restimulation with irradiated autologous PBMC but 
without TT. 
Southern analysis. Southern analysis was performed 
using a modification of previously published techniques (14). 
Briefly, purified T cell DNA was digested with either Sfil 
(Gibco-BRL, Gaithersburg, MD) and Pacl (United States 
Biochemical, Cleveland OH) or Sfil, Pacl, and Kpnl (Boehr- 
inger Mannheim). Ten micrograms of digested DNA was 
fractionated on a 1% agarose gel at 20V for 15 hours, then 
capillary-transferred to a MagnaGraph (Micro Separations, 
Westborough, MA) nylon membrane, according to the man- 
ufacturer's instructions. The membranes were hybridized 
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Figure 1. Effect of 5-azacytidine (5-azaC) and procainamide (PCA) on T cell expression of lymphocyte function-associated antigen 1 .  A cloned 
CD4+ tetanus toxoid-reactive T cell line was treated with either 0.25 @ 5-azaC or 50 pA4 PCA; 6 days later, treated and untreated cells were 
washed then stained with A, anti-CD3 or B, antLCD1 la, then fluorescein isothiocyanate-conjugated goat anti-mouse Ig, and analyzed using a 
Coulter ELITE flow cytometer. CD3 staining of untreated (C; solid line), 5-azaC-treated (A; dotted line), and PCA-treated (P; heavy line) cells 
is approximately equal. CDl la  staining of untreated cells (C; solid line) demonstrates a bimodal distribution, with peaks of approximately 20 
and 150, while 5-azaC-treated (A; dotted line) and PCA-treated (P; heavy line) cells demonstrate nearly identical histograms, with a major peak 
at 200, and a decrease in the former peak at 20. X-axis represents fluorescence intensity in arbitrary units; y-axis represents cell number. 
with 32P-labeled CD18 DNA fragments, cut as indicated in 
the text with Bum HI and Bst EII or Dpn I (Boehringer 
Mannheim), then washed, and autoradiograms were devel- 
oped using previously described procedures (8,15). 
RESULTS 
Initial experiments examined the proposed cor- 
relation between DNA hypomethylation, increased 
LFA-1 expression, and autoreactivity by comparing 
the effects of different DNA methylation inhibitors on 
T cells. We chose 5-azaC, PCA, and UV light as 
agents which inhibit DNA methylation by different 
mechanisms. 5-azaC is incorporated into newly syn- 
thesized DNA where it covalently binds DNA MTase 
(16), while PCA binds and reversibly inhibits DNA 
MTase (17). The mechanism by which UV light inhib- 
its DNA methylation is less clear, but presumably 
involves modification of cytosine residues by reactive 
oxygen species (18,19). 
Previous experiments demonstrated that 5-azaC 
and PCA inhibit T cell DNA methylation and induce 
autoreactivity (2), but LFA-1 expression was not exam- 
ined in PCA-treated clones, and UV light was not tested. 
We treated human T cell clones with 5-azaC or PCA, and 
found that CDI l a  expression on a subset of the cells was 
increased - 10-fold (from 20 units to 200 units) (Figure l), 
similar to 5-azaC- and PCA-treated polyclonal murine T 
cells (3). It should be noted that not all cells demonstrate 
an increase in CDlla expression. This is due in part to 
the fact that altered gene expression occurs, at best, in 
50% of cells treated with DNA methylation inhibitors 
(20), and in part to the percentage of cells in S phase at 
the time of treatment (7,20). In 7 serial repeats of this 
experiment using 5 distinct cloned human CD4+ T cell 
lines, the average increase in CD1 l a  expression over all 
the cells was 43 f 16% (mean f SEM; P < 0.05, by 
univariate t-test for the mean), with a range of 14-136%, 
similar to that previously found using 5-azaC (8). 
To further confirm and extend these results, 
the cloned, conalbumin-reactive murine T cell line 
D.10.G4.1 was subcloned at 0.2 cells/well, and the 
subclone treated with 25 fl  PCA. Similar results (a 
76% increase in CD1 la) were observed. This increase 
also correlated with an increase in autoreactivity 
(mean f SEM 1,484 +- 11 1 versus 11,920 f 710 counts 
per minute, untreated versus treated, response of 20,000 
T cells to 20,000 irradiated syngeneic splenocytes). 
Since the level of LFA-1 expression is in part 
dependent on T cell activation (21), it is possible that 
the increase in LFA-1 is due to changes in cell cycle 
kinetics. Therefore, the effect of PCA on cell cycling 
was examined. TT44G cells were treated with 50 pM 
PCA, and 6 days later the percentages of cells in GoGI, 
S, and G,M phases were determined using propidium 
iodide staining and flow cytometric analysis. Similar to 
previous experiments using murine T cells (3), there 
was no significant effect of PCA on T cell cycle 
kinetics (72 -+ 9% versus 62 * 4%, 15 f 6% versus 21 
f 2%, and 14 +- 4% versus 17 k 1%, untreated versus 
treated, GoGI, S ,  and G,M, respectively, mean f SD 
of 2 determinations). It remains possible that the 6-day 
drug treatment selects a subset with high LFA-I 
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Figure 2. Effect of ultraviolet (UV) light on T cell DNA methylation (A), autoreactivity (B), and CDlla  expression (C and D). A, Jurkat cells 
were exposed to the indicated amounts of UV-enriched light. Three days later, total dC and d"C content was measured by reverse-phase 
high-performance liquid chromatography. Values are the % d"C relative to total DNA dC, and are the mean * SEM of 3 independent 
experiments, each performed in duplicate (P < 0.02, untreated versus 45 J/m2). As a control, the experiments were repeated using a filter 
absorbing wavelengths shorter than 335 nm to delete UVB wavelengths, and exposure times were lengthened by a factor of 2.57 to maintain 
an equal amount of energy applied to the cells. With the filter, an exposure of 45 J/mZ gave no significant decrease (1.4 2 1.6% of control; n 
= 3 experiments) in d"C content (P < 0.02 relative to the same amount of unfiltered light). B, Phytohemagglutinin-activated interleukin-2 
(IL-2Wependent CD4+ T cells were treated with the indicated amounts of UV-containing light, with or without a 335-nm filter. Cells were 
maintained in IL-2-containing media, and 6 days later, 20,000 cells were challenged with lo5 autologous irradiated antigen-presenting cells 
(APC), with or without 10 n g h l  anti-CD3 as a positive control. Proliferation was measured 3 days later by incorporation of 'H-thymidine. 
Values are the response of the cells to APC alone relative to the response to APC plus anti-CD3 (P < 0.02, untreated versus 45 J/m*), and are 
the mean 2 SEM of quadruplicate determinations. The antLCD3 response was similar for all light exposures, averaging 13,464 2 1,933 cpm. 
C, Tetanus toxoid-reactive T cell clones were exposed to UV light, and 6 days later, stained with anti-CDlla and fluorescein isothiocyanate- 
conjugated goat anti-mouse Ig, then analyzed by cytofluorography using a Coulter EPICS C. X-axis represents log green fluorescence plotted 
as a 64-channel histogram; y-axis represents cell number. Unexposed cells are shown. D, The same cells as in C were exposed to 35 J/mZ of 
UV-containing light, then analyzed by cytofluorography as in C. Controls using the 335-nm filter showed no increase in expression of 
lymphocyte function-associated antigen 1. 
expression. However, the reproducibility of this ob- 
servation on 6 distinct cloned lines is evidence for a 
direct effect on LFA-1 expression, rather than a low- 
expressing subset contaminating all 6 lines. 
The effects of UV light on T cell DNA methyl- 
ation were examined by exposing Jurkat cells to 
varying amounts of UV-containing light, with or with- 
out a filter excluding wavelengths less than 335 nm, 
then measuring total DNA dC and d"C content by 
high-performance liquid chromatography (HPLC). 
Jurkat cells were used because HPLC quantitation of 
DNA d"C content requires larger amounts of DNA 
than can be obtained from IL-2-dependent cells. UV 
light was found to inhibit T cell DNA methylation in a 
dose-dependent manner (Figure 2A), with significant 
DNA methylation inhibition occurring by 45 J/m2. 
To test whether UV light also induces autore- 
activity, PHA-activated CD4+ T cells were exposed 
to similar amounts of UV light, then challenged with 
autologous APC, using anti-CD3 as a positive control 
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Figure 3. Southern analysis of transfectants. A, Sj I and Pac I 
digest of DNA isolated from control TTl8I cells (lane 1) and 
transfectants (lane 2) hybridized with a 1,400-bp fragment cut from 
the pEMO construct with Dpn I, containing approximately 500 bp of 
the 5' end of the CD18 insert (arrow) and 900 bp of the retroviral 
backbone (lane 2). The arrow identifies the insert. B, DNA from 
control TT18I cells digested with Sj I, Puc I, and Kpn I (lane 1) and 
transfectants digested with Sj I, Puc I, and Kpn I (lane 2) then 
hybridized with an 800-bp fragment cut entirely from the CD18 
insert with Burn HI and Bst EII. Arrow identifies the migration of the 
3.5-kb Kpn I fragment containing the CD18 cDNA, excised from the 
construct. 
(Figure 2B). UV light induced autoreactivity similar to 
that induced by other DNA methylation inhibitors (2). 
Exposing a cloned TT-reactive T cell line to similar 
amounts of UV light, then challenging with APC with 
and without TT gave identical results (mean k SEM 
autoreactive response 9,829 _+ 1,065 versus 20,587 _+ 
2,498 cpm, untreated cells versus cells treated with 35 
J/m2 [P < 0.021; antigen responses 24,232 5 965 and 
26,858 _+ 3,191, untreated versus 35 J/m2). An increase 
in LFA-1 expression (0.5-40 log green fluorescence 
units) was also seen on a subset of the T cell clones 
exposed to amounts of UV light-inhibiting DNA 
methylation and inducing autoreactivity (Figures 2C 
and D). These experiments, coupled with our previous 
results, show that all 3 DNA methylation inhibitors can 
induce autoreactivity and increase LFA- 1 expression. 
To determine if LFA-1 overexpression could 
contribute to autoreactivity , we tested whether plasmid- 
mediated LFA- 1 overexpression could also induce 
autoreactivity. Cloned TT-reactive T cells (TT181) were 
transfected simultaneously with CD1 la and CD18 con- 
structs, as described in Materials and Methods. Controls 
included untransfected cells and cells transfected with 
the parent CDM8 and pEMO vectors without inserts. 
Transfectants were selected by culturing in IL-2- 
containing media with autologous APC but without TT. 
After 6-43 weeks, a line grew out from the cells trans- 
fected with the constructs, but not from the controls. 
Identical results have been seen in 2 out of 2 repeats of 
this experiment, while lines could not be established 
using the parent expression vectors without inserts. 
We next examined whether the selected cells 
had integrated the constructs. Figure 3A shows a 
Southern blot, performed approximately 14 weeks 
after the transfection, in which DNA fragments from 
untransfected TT18I control cells and transfectants 
were hybridized with a 1,400-basepair fragment of the 
pEMO construct containing the 5' end of the CD18 
insert and a portion of the plasmid backbone. The 
experiment demonstrates genomic CD18 in both prep- 
arations, and stable integration of the construct in the 
transfectants, but not in the untransfected cells. Figure 
3B shows a blot containing DNA from control cells 
and transfectants digested with Kpn I to excise the 
CD18 insert from the pEMO construct (14). The blot 
has been hybridized with a probe derived from an 
800-bp fragment of the CD18 cDNA. Untransfected 
cells have a 3.8-kb band representing genomic CD18, 
while the transfectants show a 3.5-kb band corre- 
sponding to the CD18 insert in addition to the genomic 
CDl8 band. In contrast to CD18, the CDlla construct 
was not integrated (data not shown). 
Flow cytometric analysis was used to examine 
LFA-1 expression on the transfected cells. In these 
experiments, cells undergoing selection by stimulation 
with APC alone were serially stained for CDlla and 
CD18, using CD2 or CD3 as reference markers. All 
electroporated clones initially showed decreased 
LFA-1, CD2, and CD3 expression. However, in those 
cells which grew through selection, a subset was 
detected which overexpressed both CD1 la and CD18 
-3-fold relative to the lower-expressing subset. Figure 
4 shows this subset using cells stained for CD1 la. An 
identical subset was seen when cells were similarly 
stained for CD18 (data not shown). Using CD2 as a 
reference marker, we confirmed that the RFI of the 
population expressing lower amounts of LFA-1 had 
not changed from shortly after transfection, and that 
the population expressing greater amounts of LFA-1 
was also increased relative to CD2. These experiments 
suggest that the integrated CD18 cDNA causes an 
-3-fold increase in LFA-1 expression, relative to 
other surface markers and the control transfectants. A 
2-fold increase in CD18 expression was also seen on a 
second, autoreactive transfected line. 
The amount of antigen and number of APC 
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quirements of transfected and control cells. Similar to 
the experiments studying the requirement for APC, 
TT than did the untransfected cells, and even re- 
the transfectants responded to lower concentrations of 
Figure 4. CDlla expression in transfected TTllI cells. The trans- 
fectants described in Figure 3 were stained with anti-CDlla and 
fluorescein isothiocyanate (FITCjconjugated goat anti-mouse Ig at 
A, 4 weeks and B, 16 weeks after electroporation, then analyzed 
using a Coulter ELITE flow cytometer. At 4 weeks, there is a single 
peak at 16; by 16 weeks, there are peaks at 12 and 40. Values are the 
log FITC fluorescence (LFITC) and log green fluorescence (LGFL). 
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required for activation of the transfected and control 
cells was examined next. TT181 or TT18I transfectants 
were challenged with TT and a variable number of 
irradiated APC. The transfectants responded opti- 
mally to a lower number of APC compared with the 
untransfected cells, including numbers of APC insuf- 
ficient to stimulate the untransfected cells (Figure 5A). 
Figure 5B shows a parallel experiment in which trans- 
fected and untransfected cells were challenged with 
increasing numbers of APC without TT. The transfec- 
tants are able to respond to autologous APC without 
added TT, although the magnitude of the autoreactive 
response is smaller than the antigen-induced response. 
Experiments performed using a second similarly trans- 
fected and selected line confirmed autoreactivity 
(mean * SEM 1,365 2 118 versus 3,980 * 330 cpm, 
parent versus transfectant, 2 x lo4 T cells and lo5 
PBMC). This autoreactive response may be responsi- 
ble for the continued growth of the transfected cells 
without antigen. Figure 5C compares the antigen re- 
experiments, the magnitude of the optimal response by 
the transfectants is also greater than that observed 
with the untransfected cells. The reason for this is not 
clear, but it is possible that increased LFA-1 expres- 
sion facilitates T cell-APC interactions, leading to 
activation of a greater percentage of T cells. 
Since experiments in the 5-azaC system had 
shown that the autoreactive response was more sensi- 
tive to anti-LFA-1 inhibition than was the antigen 
response, we next asked if the autoreactive response 
inhibition with anti-LFA-1 than was the antigen re- 
sponse (Figure 5D). Using a fixed number of T cells 
and APC that simultaneously give significant and 
measurable antigen and autoreactive responses, anti- 
CDl la inhibited the autoreactive response by 74 * 6% 
(mean f SEM) and the TT response by 36 k 3% (P < 
0.01). In this experiment, the autoreactive response was 
of greater magnitude than the antigen response. This is 
because it is important to use the same number of 
ligand-bearing APC and T cells for both the antigen and 
autoreactive responses to compare effects of the same 
amount of antibody. In contrast to the effect of anti- 
CD1 la-containing ascites, identical concentrations of 
mouse ascites containing a noninhibitory anti-CD1 l a  
(TA-1) had no significant effect on T cell activation (99.6 
f 4.2% of control, mean k SEM of 2 experiments). 
These results support the idea that the autore- 
active response is more sensitive to inhibition by the 
same amount of antibody than is the antigen response, 
similar to 5-azaC-treated cells. Together, these exper- 
iments suggest that LFA-1 overexpression mediated 
indirectly by treatment with DNA methylation inhibi- 
tors or directly by plasmid transfection is associated 
with T cell autoreactivity. 
DISCUSSION 
One goal of this laboratory is to determine how 
5-azaC makes T cells autoreactive. The many effects 
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Figure 5. Activation requirements of control and transfected TTl8I cells. A, Effect of transfection on antigen-presenting cell (APC) 
requirements for antigen-induced responses. TT181 or TT18I transfectants (5 x lo4 cells) were challenged with tetanus toxoid (n; diluted 150) 
and the indicated number of irradiated autologous APC. Proliferation was measured as described in Figure 2. Values are the mean * SEM of 
triplicate determinations. B, Effect of transfection on APC requirements for autoreactive responses. Transfected and untransfected TTl8I cells 
(5 X lo4) were challenged with increasing numbers of irradiated autologous AFT without TT. 3H-thymidine incorporation by the irradiated APC 
alone is also shown (P < 0.02, transfected versus control at lo6 APC). C, Effect of transfection on antigen requirements. Transfected or control 
TTllI cells (20,000) were cultured with lo5 irradiated autologous APC and the indicated dilutions of TT. Values are the mean ? SEM of 
quadruplicate determinations. D, Effect &anti-lymphocyte functionassociated antigen 1 on antigen reactivity and autoreactivity in transfected 
cells. Transfected TTlSI cells (5  x lo4) were challenged with lo6 autologous irradiated APC, with or without TT (diluted 150). Solid bars show 
cultures without added antibody; hatched bars show those with antLCD1 la (1:1,OOO). 
of 5-azacytidine on cells (22) suggest multiple possible 
mechanisms by which autoreactivity may be induced. 
However, at concentrations inducing autoreactivity, 
the predominant effect is DNA methylation inhibition 
(22,23). Therefore, it seems reasonable to propose that 
the autoreactivity is due to altered expression of one 
or more T cell genes regulated by DNA methylation. 
Previous experiments had examined T cell clones for 
changes in gene expression induced by 5-azaC. Two- 
dimensional polyacrylamide gel electrophoresis of to- 
tal cellular proteins and '251-labeled membrane pro- 
teins were used to screen for new gene expression 
induced by 5-azaC. However, no unique changes in 
cytoplasmic or cell surface polypeptides were ob- 
served (8). Similarly, immunoprecipitates of the T cell 
receptor (TCR) showed no changes in structure (8). 
Flow cytometry was also used to examine alterations 
in the expression of T cell surface molecules following 
treatment with 5-azaC. No change was seen in the 
expression of CD1, 2, 3, 4, 5 ,  7, 8, 10, 25, 29, 30, 34, 
38,43,44,45RA, 45RO,53,54,56,57,58, w60,69,70. 
73, 4F2, or TCRoJp (8). 
More recently, an increase in CD28 has been 
observed in newly established clones, but this marker 
disappeared with time as reported by others (24), and 
was not re-expressed following 5-azaC treatment. 
However, the cells still became autoreactive, suggest- 
ing that CD28 was not likely to participate in the 
autoreactivity. CD6 up-regulation, which might con- 
tribute to autoreactivity, was demonstrated on 3 of 4 
cloned lines. HLA-DR expression increased on 1 of 5 
cloned lines, as did CD26, 46, and 48 (unpublished 
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results). Each of these molecules has been implicated 
in T cell activation (25-28), but the failure to alter 
expression on all clones raises questions about their 
role in inducing autoreactivity. Finally, more recent 
experiments have shown no alterations in T cell Fas 
expression induced by 5-azaC (unpublished results). 
Using a panel of 5 cloned T cell lines, the most 
reproducible change induced by 5-azaC was an in- 
crease in LFA-1 expression (8). Kinetic analysis re- 
vealed that CDlla  expression usually began to in- 
crease 3 days after 5-azaC treatment and was maximal 
by day 4, correlating with autoreactivity (8). A role for 
LFA- 1 overexpression in autoreactivity was suggested 
by experiments in which small amounts of anti-LFA-1 
were found to completely inhibit autoreactivity with- 
out affecting antigen reactivity (8). This is consistent 
with the interpretation that inhibiting the effects of the 
increased number of LFA-1 molecules would reverse 
the autoreactivity , suggesting that the increase in 
LFA- 1 might cause the autoreactive response. 
The current observations that PCA and UV 
light also induce autoreactivity and increase LFA-1 
expression on T cell clones further support this asso- 
ciation. It should be noted that earlier studies demon- 
strated that PCA also increases LFA-1 expression on 
murine CD4+ T cells (3). However, those studies were 
performed using polyclonal cells, so it was not clear 
whether PCA treatment was selected for cells with 
greater LFA- 1 expression or directly increased LFA- 1 
expression. We have now confirmed the correlation 
between increased LFA- 1 expression and autoreactiv- 
ity using a cloned murine T cell line as well. The 
previous and present observations that 5-azaC, PCA, 
and UV light increase LFA-1 on human and murine T 
cell clones while inducing autoreactivity provide evi- 
dence for a direct effect of these agents on LFA-1 
expression, and support the proposed correlation be- 
tween increased LFA- 1 expression and autoreactivity . 
Transfection experiments tested the hypothesis 
that LFA-1 overexpression alone can contribute to 
autoreactivity. In these experiments, TT-reactive cells 
were transfected with cDNAs that encode LFA- 1 
subunits, and transfectants selected for autoreactivity. 
Autoreactive lines were established using this ap- 
proach, and the line selected for study had stably 
incorporated the CD18 cDNA. These cells demon- 
strated increased LFA-1 expression, and the cells 
were able to respond to signals which were insufficient 
to activate untransfected cells, including APC without 
specific antigen. The autoreactive response was more 
sensitive to inhibition with anti-LFA-1 than was the 
antigen response, similar to the 5-azaC-treated cells. 
Together, these results are consistent with the inter- 
pretation that an increase in LFA- 1, caused by over- 
expression of one of its subunits, permits T cells to 
respond to normally subthreshold activation signals, 
either by providing additional stabilization to the 
TCR-MHC-antigen complex or by providing stronger 
transmembrane signals (29). The magnitude of the 
autoreactive response observed in the transfected cells 
is less, relative to the antigen response, than is the 
autoreactivity induced by DNA methylation inhibitors 
(1,2). This may reflect the relatively smaller increase in 
LFA-1 achieved by transfection, compared to treat- 
ment with DNA methylation inhibitors, or possibly 
effects of DNA methylation inhibitors on other gene 
products, such as CD6. In contrast, the antigen re- 
sponse of the transfectants is significantly greater than 
the antigen response of the controls, presumahly also 
due to LFA-1 overexpression. 
The transfection experiments raise the question 
as to why the CDlla construct was not incorporated 
into the DNA. One explanation is that the transfection 
process in T cell clones is relatively inefficient, such 
that recombination events are rare, and incorporation 
of the CDl8-pEM0 construct, rather than the CD1 la- 
CDM8 construct, was by chance. It is also possible 
that pEMO, the vector used to transfect the CD18 
cDNA, may be more efficient in incorporating into 
human lymphocyte DNA than CDM8, which was used 
with CDl la. This is supported by the recent successful 
stable transfection of human B cells with the same 
pEMO-CD18 construct (14). 
Other interpretations of the transfection ex- 
periments were considered. It is possible that the 
transfection process, or incorporation of the vector 
backbone alone, contributed to the autoreactivity. 
However, these explanations are unlikely for 3 rea- 
sons. First, attempts to establish autoreactive lines 
using the parent expression vectors were unsuccess- 
ful. This indicates that the transfection process alone 
does not produce autoreactive cells through random 
insertion of a vector, and that the parent vectors alone 
are insufficient to produce autoreactivity. Second, the 
observation that the transfected cells respond to nor- 
mally subthreshold stimulatory signals is consistent 
with known effects of LFA-1, which has previously 
been shown to stabilize low-affinity TCR interactions 
(30). Third, the autoreactivity could be preferentially 
reversed using small amounts of anti-LFA-1, consis- 
tent with the interpretation that inhibiting the function 
of the additional LFA-1 molecules reverses the auto- 
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reactivity. It will be important to confirm these results 
by transfecting cells with a construct containing both 
the CD18 cDNA and a drug-resistance marker, select- 
ing for the marker, then determining whether the 
transfectants overexpress LFA- 1 and are autoreac- 
tive. These experiments would be more appropriately 
performed using murine cells, however, because auto- 
reactivity could be confirmed by adoptive transfer 
experiments, looking for induction of autoimmunity 
similar to that caused by 5-azaC- and PCA-treated 
cells (3). This approach could also be used to test the 
effects of overexpressing other genes in T cells. 
The autoreactivity induced by LFA-1 over- 
expression has relevance to human lupus. As shown 
above and elsewhere (Z), agents known to trigger 
lupus, such as PCA and UV light, increase T cell 
LFA-1 expression and induce autoreactivity, and mu- 
rine T cells made autoreactive with 5-azaC or PCA 
cause lupus in syngeneic mice (3). It is possible that 
the LFA-1 overexpression contributes to the lupus- 
like disease seen in this system. It is also interesting to 
note that the amount of UV light needed to inhibit 
DNA methylation and induce autoreactivity is approx- 
imately one-tenth that which causes a sunburn in 
Caucasians (31), supporting the hypothesis that UV 
light exposure in amounts frequently encountered by 
lupus patients could have an effect on their T cells. 
Finally, we have reported that patients with idiopathic 
lupus have impaired T cell DNA methylation (9, and 
that patients with active lupus have an autoreactive T 
cell subset identified by a relative overexpression of 
LFA-1, similar to 5-azaC- or PCA-treated cells (8). 
Together, these observations support a model in which 
LFA-1 expression is abnormally increased on CD4+ T 
cells, possibly by mechanisms involving DNA hypo- 
methylation, and leading to T cell autoreactivity. The 
autoreactive T cells may then mediate a lupus-like 
autoimmune disease. 
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